Carbon dioxide laser assisted sclerectomy surgery (CLASS) is being used as an effective and safe, minimally invasive treatment for glaucoma. In this article, two surgeons at the forefront of research, development and implementation of this approach discuss this surgical option and its benefits for the ophthalmic market.
"We resort to traditional penetrating surgical methods such as trabeculectomy and tube shunts when the state of the disease is dire enough to exceed the high risks associated with these treatments," explained Prof. Assia.